Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The firm was able to raise approximately US$2.5 million in its debut on the big board.

The offering consisted of 625,000 American depository shares at US$4.00 per share. The company’s shares are trading under the symbol “OKYO”.

Proceeds of the offering are intended for advancing the firm’s drug candidate OK-101 to filing an investigative new drug application, funding the drug’s phase 2 clinical trial, and for working capital and other general corporate purposes.

ThinkEquity acted as the sole bookrunner for the said offering.

The London-based life sciences company is focused on treating patients suffering from inflammatory eye diseases and ocular pain. It is presently developing its lead preclinical product candidate OK-101 to treat dry-eye disease.

OKYO Pharma last traded at US$3.00 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Electric Vehicle Maker Iconiq Motors To Be Taken Public In A US$2.5 Billion SPAC Merger

Electric vehicle company Iconiq Motors entered into a definitive business combination agreement with special purpose...

Monday, April 18, 2022, 02:24:00 PM

It’s Been A Painful Year For IPOs, Proceeds Are Down 93%

It hasn’t been a good year for companies going public  — uncertainty from mounting recession...

Monday, December 5, 2022, 03:06:00 PM

Renewable Energy SPAC AP Acquisition Prices US$150 Million IPO

Special purpose acquisition company AP Acquisition Corp (NYSE: APCA.U) went public today on the New...

Friday, December 17, 2021, 02:23:00 PM

European Investment Firm-Backed SPAC Springwater Special Situations Eyes US$150 Million IPO On Nasdaq

Special purpose acquisition company Springwater Special Situations Corp. (Nasdaq: SWSSU) started trading its securities on...

Thursday, August 26, 2021, 01:10:00 PM

Biotech Firm Blue Water Vaccines Prices US$20 Million IPO

Biopharmaceutical company Blue Water Vaccines, Inc. (Nasdaq: BWV) began trading on the Nasdaq Capital Market...

Monday, February 21, 2022, 04:33:00 PM